Mr. Avijit Bej

Core area of interested includes Experimental Pharmacology, Toxicology, Diabetic wound healing, Stem cell therapy in cardiac pyroptosis, Tyrosine kinase as a target for neurodegenerative diseases and Organ chip model.

He has over 2 years of academic experience. His research domain focused on the synthesis of silver nanoparticles and the evaluation of their antibacterial properties, along with their interaction with lung cancer DNA. This interdisciplinary work integrates nanotechnology and pharmacology, aiming to explore novel therapeutic approaches. He has 1 research publication in a reputed journal. Additionally, he has presented posters at one national and two international conferences.